Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease iga nephropathy
Comorbidity C0033687|proteinuria
Sentences 18
PubMedID- 24721885 Conclusions: the findings in this cohort and previous studies suggest that rare cases of mild iga nephropathy with nephrotic range proteinuria exhibit a clinical presentation, biopsy findings, treatment response, and outcome more typical of iga nephropathy with superimposed minimal change disease.
PubMedID- 26239462 Urinary ngal levels also correlated with the degree of proteinuria in patients with iga nephropathy [16] and membranous nephropathy [14,15].
PubMedID- 21533280 Recently, cheng's review [46] illustrated that glucocoticoids significantly induced a protection of renal function and a reduction of proteinuria in patients with iga nephropathy.
PubMedID- 23977072 Discussed, the course of iga nephropathy with initial proteinuria <1 g/day is variable according to the change of proteinuria during the follow-up period [27].
PubMedID- 23331443 Conclusion: for early iga nephropathy patients with minimal proteinuria, normal blood pressure, and normal renal function, treatment with 2.5 mg/daily of ramipril for 5 years does not offer any benefit.
PubMedID- 22019331 Conclusions: the addition of calcitriol to a renin-angiotensin system inhibitor resulted in a safe decrease in proteinuria in patients with iga nephropathy.
PubMedID- 20826744 Conclusions: among patients with primary glomerulopathy and nephrotic-range proteinuria, normoalbuminaemia is associated with iga nephropathy.
PubMedID- 24707402 Before the eradication therapy the mean proteinuria of patients with mn, iga nephropathy and fsgs were 2.42 +/- 3.24 g/day, 2.12 +/- 1.63 g/day and 1.80 +/- 1.32 g/day, respectively.
PubMedID- 20594038 The authors measured the extent of foot process effacement in 100 iga nephropathy cases with proteinuria and correlated it with the amount of proteinuria.
PubMedID- 23197956 Successful treatment of adult iga nephropathy with nephrotic-level proteinuria by combination therapy including long-term coadministration of mizoribine.
PubMedID- 23557791 Aims: both steroid pulse (sp) monotherapy and the combination of tonsillectomy and sp therapy (tsp) are effective for achieving clinical remission (cr), defined as negative hematuria and proteinuria, in patients with iga nephropathy (igan).
PubMedID- 22456060 Some iga nephropathy (igan) patients with massive proteinuria showed resistance to steroids and/or cytotoxic immunosuppressants based on the supportive therapy with renin- angiotensin system blockade.
PubMedID- 23049672 Oral calcitriol treatment reduced proteinuria in patients with iga nephropathy [172].
PubMedID- 20843592 Conclusions: thujone-free wormwood with its favorable safety profile can be an alternative supplement to manage proteinuria in patients with iga nephropathy.
PubMedID- 24131475 Conclusion: immunoglobulin a nephropathy patients with lower proteinuria had higher galnac exposure rates.
PubMedID- 21655166 [2122] the ii genotype has been reported to be associated with more favorable prognosis and decreased proteinuria in patients with iga nephropathy.
PubMedID- 23713873 Calcitriol (0.5 microg calcitriol twice per week) has been effective in decreasing proteinuria in patients with iga nephropathy.
PubMedID- 26289088 Background: sometimes, acute and progressive proteinuria increases occur in patients with iga nephropathy (igan) after favorable long-term clinical courses of >10 years, but their clinical and histological characteristics are not well understood.

Page: 1